MEDICINE

Wall Street's push for record profits is ruining careers, tearing apart families and keeping drug dealers busy, mental health experts say.

Colgate-Palmolive Co. on Thursday said counterfeit 'Colgate' toothpaste that may contain a toxic chemical had been found in discount stores in four U.S. states.

Last week, Dr. Naresh Trehan, the top cardiologist at one of India’s largest corporate hospital groups, playing the role of a modern-day Moses, quit the research center he had led for the last 20 years, triggering an exodus of sorts, with about 50 doctors set to follow him to a rival hospital.

Advanced Medical Optics Inc. (NYSE: EYE) said it is considering an offer for Bausch & Lomb Inc. (NYSE: BOL), setting up what could become bidding war with the private equity firm Warburg Pincus LLC.

The Ministry of Economy, Trade and Industry in Japan is now requiring home appliance manufacturers to report serious accidents caused by their products, according to a report by Asashi Shimbun on Monday.

Johnson & Johnson wholly owned firm Conor Medsystems LLCsaid, said on Monday that it will end clinical trials of its CoStar drug coated stent after it failed to meet its primary goal.

Shares of biotechnology firm Amgen, Inc. (Nasdaq: AMGN) shot up 4 percent Thursday, after results of a study for its Aranesp anemia drug for patients with small-cell lung cancer yielded no difference in survival rates than for patients who did not use the drug.

The Supreme Court upheld the nationwide ban on a controversial abortion procedure Wednesday, handing abortion opponents the long-awaited victory they expected from a more conservative bench.

Biotechnology firm Cell Genesys Inc. (Nasdaq: CEGE) shares rose sharply Tuesday, after the company said its prostate cancer drug therapy showed better-than-expected results in a clinical trial.

Shares of drug maker Cephalon (NASDAQ: Cephalon) jumped in Monday trading as a Wall Street Brokerage Firm raised the rating of the stock on Monday despite a delay in approval for a new drug.

Shares of biotechnology firm Novavax (Nasdaq: NVAX) leaped in morning trading following an announcement that its vaccine against avian flu seems effective in small animals.

Shares of Nuvelo, Inc. (Nasdaq: NUVO) skyrocketed on Tuesday following news that drug maker's cancer drug was granted 'fast-track' status by the U.S. Food and Drug Administration.

Shares of Regeneron Paharmaceuticals, Inc. (Nasdaq: REGN) soared Tusday after initial results of a study involving treatment to prevent a leading cause of age-related acquired blindness showed significant results.

Drug maker Alexza Pharmaceuticals, Inc. (Nasdaq:ALXA) said that two of its drugs for treating schizophrenic patients showed positive initial results in clinical trials, sending its shares skyrocketing.

Shares of Boston Scientific (NYSE: BSX) dropped to their lowest price since 2002 on Monday, while shares of Abbott laboratories (NYSE: ABT) rose after a medical study showed that Abbot's stent device was better at treating clogged heart arteries.

U.S. health officials have cleared a hair-combing consumer laser product to treat baldness in men, the manufacturer said Thursday.

The first U.S. non-prescription weight loss pill was approved this week by U.S. health officials.

With the New Year sure to bring many weight loss resolutions, fast-casual restaurant Boston Market is launching a web marketing promotion to present its food offerings as healthy and affordable solutions for reducing excess belly fat.

More consumers are utilizing the internet for researching prescription medication information, a new study finds, with depression remaining the leading condition researched online.

Sony Electronics introduced high-definition technology for medical surgery on Monday, rolling out equipment allowing practitioners to see details of patients at never-before resolutions.

Wal-Mart said Thursday it will implement its $4 generic prescription program in Florida tomorrow. The rollout comes four months earlier than originally planned.